A Prospective, Controlled Study of Double Filtration Plasmapheresis (DFPP) in Patients With Antineutrophil Cytoplasmic Autoantibody Associated Glomerulonephritis (AAGN)

NCT02294344 NA TERMINATED

The clinical efficacy of double filtration plasmapheresis(DFPP) in patients with antineutrophil cytoplasmic autoantibody associated glomerulonephritis(AAGN).

Details

Lead sponsor	Zhi-Hong Liu, M.D.
Phase	NA
Status	TERMINATED
Enrolment	14
Start date	2014-06
Completion	2017-04

Conditions

• Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Interventions

• DFPP&CTX
• CTX

Primary outcomes

• the renal recovery rate — 3 months
  the renal recovery rate at 3 mo defined by dialysis independence and the SCr \<5mg/dl for the patients needed renal replacement therapy at the basement, or the SCr decreased more than 30% of the baseline and the urine sediment red blood cell less than 50\*104/ml for the patients without renal replacement at the basement.

Countries

China